BMAL1 and neoplasm: We found that knockdown of Myh9 in YUMM2.1 EV (Fig. 7a) increased tumor growth equivalent to WT-Bmal1 (Supplementary Fig. 7a) compared to control shNC YUMM2.1 EV tumors in C57BL/6 mice.